Kyverna Therapeutics (Series A)
Funding Details
Awarder
Inbox
Date Award
January 14, 2020
Vertical
Cell Therapy
Funding Amount
$25,000,000
Company Info
Founders
Dominic Borie
Market
Autoimmune Diseases
Location
Berkeley, California, USA
Coinvestors
Gilead Sciences, Vida Ventures, Westlake Village BioPartners
Company Description

Kyverna Therapeutics is pioneering a new class of therapies and cures for serious autoimmune diseases.